This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: The Innovations of Daniel Nathan Andrew LaFoc
Introduction
Daniel Nathan Andrew LaFoc is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of cancer research through his innovative work on gene suppression. His dedication to advancing medical science is evident in his patented inventions.
Latest Patents
LaFoc holds a patent for the Mini-E1A gene and gene products. This invention provides methods and compositions for the suppression of oncogenic transformation, tumorigenesis, and metastasis. The patent discloses functional domains of E1A responsible for the suppression of transformation and offers mini-E1A constructs that can be utilized for tumor suppression. Additionally, it outlines novel methods for using mini-E1A in combination with chemotherapeutic drugs and/or tyrosine kinase inhibitors.
Career Highlights
LaFoc is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His work has the potential to impact cancer treatment significantly, providing new avenues for therapeutic interventions.
Collaborations
LaFoc has collaborated with notable researchers in his field, including Mien-Chie Hung and Hua Chen. These partnerships have further enhanced the scope and impact of his research.
Conclusion
Daniel Nathan Andrew LaFoc is a prominent figure in cancer research, with a focus on innovative gene therapies. His contributions through patents and collaborations are paving the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile